Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300690180> ?p ?o ?g. }
- W4300690180 endingPage "1954" @default.
- W4300690180 startingPage "1936" @default.
- W4300690180 abstract "The host immune system possesses an intrinsic ability to target and kill cancer cells in a specific and adaptable manner that can be further enhanced by cancer immunotherapy, which aims to train the immune system to boost the antitumor immune response. Several different categories of cancer immunotherapy have emerged as new standard cancer therapies in the clinic, including cancer vaccines, immune checkpoint inhibitors, adoptive T cell therapy, and oncolytic virus therapy. Despite the remarkable survival benefit for a subset of patients, the low response rate and immunotoxicity remain the major challenges for current cancer immunotherapy. Over the last few decades, nanomedicine has been intensively investigated with great enthusiasm, leading to marked advancements in nanoparticle platforms and nanoengineering technology. Advances in nanomedicine and immunotherapy have also led to the emergence of a nascent research field of nano-immunotherapy, which aims to realize the full therapeutic potential of immunotherapy with the aid of nanomedicine. In particular, nanocarriers present an exciting opportunity in immuno-oncology to boost the activity, increase specificity, decrease toxicity, and sustain the antitumor efficacy of immunological agents by potentiating immunostimulatory activity and favorably modulating pharmacological properties. This review discusses the potential of nanocarriers for cancer immunotherapy and introduces preclinical studies designed to improve clinical cancer immunotherapy modalities using nanocarrier-based engineering approaches. It also discusses the potential of nanocarriers to address the challenges currently faced by immuno-oncology as well as the challenges for their translation to clinical applications." @default.
- W4300690180 created "2022-10-04" @default.
- W4300690180 creator A5019012003 @default.
- W4300690180 creator A5030900005 @default.
- W4300690180 creator A5060821405 @default.
- W4300690180 creator A5062147572 @default.
- W4300690180 creator A5069205879 @default.
- W4300690180 creator A5088454768 @default.
- W4300690180 date "2022-10-03" @default.
- W4300690180 modified "2023-10-16" @default.
- W4300690180 title "Nanocarriers for cancer nano-immunotherapy" @default.
- W4300690180 cites W1487513433 @default.
- W4300690180 cites W1509514214 @default.
- W4300690180 cites W1510865194 @default.
- W4300690180 cites W1551511388 @default.
- W4300690180 cites W1553589968 @default.
- W4300690180 cites W1778865595 @default.
- W4300690180 cites W1909899750 @default.
- W4300690180 cites W1913360039 @default.
- W4300690180 cites W1922412259 @default.
- W4300690180 cites W1963483847 @default.
- W4300690180 cites W1970763651 @default.
- W4300690180 cites W1973671987 @default.
- W4300690180 cites W1976892064 @default.
- W4300690180 cites W1981054482 @default.
- W4300690180 cites W1983310647 @default.
- W4300690180 cites W1984334584 @default.
- W4300690180 cites W1987155779 @default.
- W4300690180 cites W1990602451 @default.
- W4300690180 cites W1991385476 @default.
- W4300690180 cites W1991575509 @default.
- W4300690180 cites W1994993231 @default.
- W4300690180 cites W1995024863 @default.
- W4300690180 cites W2001297846 @default.
- W4300690180 cites W2003417814 @default.
- W4300690180 cites W2003699527 @default.
- W4300690180 cites W2008939735 @default.
- W4300690180 cites W2009682425 @default.
- W4300690180 cites W2028417270 @default.
- W4300690180 cites W2030132644 @default.
- W4300690180 cites W2031356741 @default.
- W4300690180 cites W2032760352 @default.
- W4300690180 cites W2038163024 @default.
- W4300690180 cites W2039123767 @default.
- W4300690180 cites W2044835625 @default.
- W4300690180 cites W2047952213 @default.
- W4300690180 cites W2048203189 @default.
- W4300690180 cites W2051247819 @default.
- W4300690180 cites W2051665875 @default.
- W4300690180 cites W2053929414 @default.
- W4300690180 cites W2064472998 @default.
- W4300690180 cites W2080023722 @default.
- W4300690180 cites W2080428594 @default.
- W4300690180 cites W2082150850 @default.
- W4300690180 cites W2084852062 @default.
- W4300690180 cites W2095412415 @default.
- W4300690180 cites W2100327051 @default.
- W4300690180 cites W2101873325 @default.
- W4300690180 cites W2104885590 @default.
- W4300690180 cites W2106554737 @default.
- W4300690180 cites W2107854895 @default.
- W4300690180 cites W2115030453 @default.
- W4300690180 cites W2115583652 @default.
- W4300690180 cites W2117326659 @default.
- W4300690180 cites W2119591285 @default.
- W4300690180 cites W2124427232 @default.
- W4300690180 cites W2126044151 @default.
- W4300690180 cites W2130456376 @default.
- W4300690180 cites W2131746203 @default.
- W4300690180 cites W2133818380 @default.
- W4300690180 cites W2134992227 @default.
- W4300690180 cites W2143163879 @default.
- W4300690180 cites W2143463421 @default.
- W4300690180 cites W2143772132 @default.
- W4300690180 cites W2144733364 @default.
- W4300690180 cites W2155128179 @default.
- W4300690180 cites W2156823146 @default.
- W4300690180 cites W2156840401 @default.
- W4300690180 cites W2165647061 @default.
- W4300690180 cites W2166662937 @default.
- W4300690180 cites W2167028666 @default.
- W4300690180 cites W2168234885 @default.
- W4300690180 cites W2173359203 @default.
- W4300690180 cites W2255455792 @default.
- W4300690180 cites W2291789394 @default.
- W4300690180 cites W2295202170 @default.
- W4300690180 cites W2315098267 @default.
- W4300690180 cites W2316953565 @default.
- W4300690180 cites W2329974159 @default.
- W4300690180 cites W2344644350 @default.
- W4300690180 cites W2346153300 @default.
- W4300690180 cites W2412158473 @default.
- W4300690180 cites W2427645657 @default.
- W4300690180 cites W2463106493 @default.
- W4300690180 cites W2465860350 @default.
- W4300690180 cites W2471739061 @default.
- W4300690180 cites W2554094503 @default.
- W4300690180 cites W2558257430 @default.